financetom
Business
financetom
/
Business
/
What's Going On With Intel Shares Friday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Intel Shares Friday?
Jan 31, 2025 7:59 AM

Intel Corporation ( INTC ) stock originally traded higher on Friday but has since reversed and began trading lower after the company on Thursday reported 2024 fiscal-year fourth-quarter earnings.

Intel ( INTC ) reported sales of $14.30 billion, beating analysts estimate of $13.81 billion, but representing a 7% year-over-year decline. In addition, it reported adjusted earnings per share of 13 cents, beating analysts estimate of 12 cents.

“Our renewed focus on strengthening and simplifying our product portfolio, combined with continued progress on our process roadmap, is positioning us to better serve the needs of our customers. Dave and I are taking actions to enhance our competitive position and create shareholder value,” said Michelle Johnston Holthaus, interim co-CEO of Intel ( INTC ) and CEO of Intel Products.

Intel ( INTC ) announced guidance for the 2025 fiscal-year first-quarter. It sees revenue between $11.7 billion and $12.7 billion, versus analysts estimate of $12.87 billion. Intel ( INTC ) guided Non-GAAP earnings per share of $0, versus analysts estimate of 9 cents.

“Our Q1 outlook reflects seasonal weakness magnified by macro uncertainties, further inventory digestion and competitive dynamics. We will remain highly focused on execution to build on our progress and unlock value,” said David Zinsner, interim co-CEO and CFO of Intel ( INTC ).

Analyst Changes: Following the earnings report, several analysts issued price target adjustments.

Roth MKM analyst Suji Desilva maintained a Neutral rating on Intel ( INTC ) and lowered the price target from $25 to $20.

Needham analyst Quinn Bolton reiterated a Hold rating on Intel ( INTC ).

Benchmark analyst Cody Acree reiterated a Hold rating on Intel ( INTC ).

Related Link: Earnings Breakdown: Orrstown Finl Servs Q4

INTC Price Action: At the time of writing, Intel ( INTC ) shares are moving 1.04% lower at $19.80, according to data from Benzinga Pro.

Image: via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Robinhood Markets Insider Sold Shares Worth $6,798,677, According to a Recent SEC Filing
Robinhood Markets Insider Sold Shares Worth $6,798,677, According to a Recent SEC Filing
Nov 6, 2025
05:07 PM EST, 11/06/2025 (MT Newswires) -- Steven M. Quirk, Chief Brokerage Officer, on November 04, 2025, sold 48,350 shares in Robinhood Markets ( HOOD ) for $6,798,677. Following the Form 4 filing with the SEC, Quirk has control over a total of 70,279 Class A common shares of the company, with 70,279 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1783879/000178387925000312/xslF345X05/wk-form4_1762466506.xml ...
Life sciences company Seer's Q3 net loss narrows
Life sciences company Seer's Q3 net loss narrows
Nov 6, 2025
Overview * Seer Q3 2025 revenue rose 2% yr/yr to $4.1 mln, driven by product and service sales * Net loss for Q3 2025 was $18.2 mln, an improvement from $21.3 mln last year * Company saw robust demand for Proteograph ONE, increasing instrument shipments Outlook * Seer expects full-year 2025 revenue between $17 mln and $18 mln Result Drivers...
Karman Q3 Adjusted Earnings, Revenue Rise; Raises 2025 Revenue Outlook
Karman Q3 Adjusted Earnings, Revenue Rise; Raises 2025 Revenue Outlook
Nov 6, 2025
05:07 PM EST, 11/06/2025 (MT Newswires) -- Karman ( KRMN ) reported Q3 adjusted earnings late Thursday of $0.10 per diluted share, up from $0.04 a year earlier. Analysts surveyed by FactSet expected $0.11. Revenue for the quarter ended Sept. 30 was $121.8 million, up from $86 million a year earlier. Analysts surveyed by FactSet expected $118.1 million. The company...
Treace Medical Q3 revenue slightly beats estimates, helped by greater market penetration
Treace Medical Q3 revenue slightly beats estimates, helped by greater market penetration
Nov 6, 2025
Overview * Treace Medical Q3 revenue grows 11% yr/yr, slightly beating analyst expectations * The bunion correction implants maker reports Q3 net loss of $16.3 mln, adjusted EBITDA improves by 49% * Treace revises full-year 2025 revenue guidance downward due to shifting surgeon preferences Outlook * Treace revises 2025 revenue guidance to $211 mln-$213 mln, down from $224 mln-$230 mln...
Copyright 2023-2026 - www.financetom.com All Rights Reserved